SAMHD1 Reduces Efficiency of Nucleoside Analog Ara-C Against AML Cells

This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication. This figure illustrates how SAMHD1, a dNTP hydrolase, reduces the efficiency of nucleoside analog, Ara-C, against acute myeloid leukemia (AML) cells. Once inside the AML cells, the inactive Ara-C gets triphosphorylated (Ara-CTP). In SAMHD1-low AML cells, Ara-CTP inhibits DNA replication, leading to apoptosis. In SAMHD1-high AML cells, Ara-CTP is recognized as a SAMHD1 substrate and is converted back to inactive Ara-C. Here, DNA replication progresses and the cells are protected from apoptosis.

Yes, you can customize this template with a free BioRender account (no credit card required). Paid plans unlock additional export formats, higher-resolution downloads, and publication permissions.

Yes, every element is fully editable. Icons, labels, colors, arrows, shapes and layout can all be changed to match your preferences or needs using BioRender's drag-and-drop editor. You can add or remove elements to fully customize your use case.

Yes, BioRender icons and templates meet journal, grant, and copyright standards for publication, and many researchers cite BioRender directly in their figure legends.

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Researchers and scientists use this template for publications, funding proposals, grant applications, presentations, posters, and more.